Axplora

More than 600 ADCs are currently in development worldwide — and timelines are accelerating.

As programs move faster, the need for integrated, reliable ADC manufacturing has never been greater.

Our latest investment at Le Mans 🇫🇷 strengthens our ability to support complex ADC programs with greater control, speed and predictability — from early development to commercial supply.

We’re proud to contribute to the supply chain of 6 of the 14 FDA-approved ADCs on the market today — and we continue to invest where it matters most.

🔗 Full announcement — link in bio.

🚀 From Earth… to the edge of human performance.

As takes flight, the world holds its breath — watching speed, precision and endurance push human limits.
And it leans on the quiet forces that make greatness possible.

At Axplora, exploration is a shared instinct.
Across our global network — 2,000+ people, 9 sites, 900+ partners — we go further, together.

Right near the Olympic heart, Gropello Cairoli stands as a symbol of that journey — 100+ years of experience, helping medicines reach over one million patients.

The athletes will shine on ice and snow.
We’ll keep enabling performance, long before the world is watching.

🌌 Milano Cortina 2026 is here.

🚀✨ Going the extra mile for you this holiday season 🎄

Whether you’re a client, partner, or colleague, when your mission really matters, you don’t just fly — you go interstellar.
Together, we deliver with precision, speed, and reliability, helping critical medicines reach patients right on time.

Because for all of us — and the patients we serve — timing is everything.

✨ Wishing you a stellar holiday season.

🚀 Mission Accomplished: Frankfurt 2025 🌌

What an incredible journey! Thank you to all our partners, colleagues, and visitors who helped make this event truly out of this world. ✨

Your energy and collaboration powered our mission — together, we explored new frontiers in pharma innovation. 🌍💫

Until our next adventure… see you at CPHI Milano 2026 (if not before)! 👋🇮🇹

No patient should wait for the medicines they need. 🌟

In 2025, more than €100 million is being invested across our global network—strengthening capacity and expanding capabilities so life-changing therapies reach patients faster, more reliably, and at scale.

With 30+ years of cGMP expertise, >600 m³ of flexible reactor capacity, and the trust of 900+ customers, Axplora has supported 13 FDA-approved molecules in the past five years.

New projects across France, Italy, and India will reinforce our leadership in small-molecule APIs and accelerate growth in ADCs and GLP-1 peptides.

🔗 Tap the link in our bio to visit our newsroom.

🏆 Axplora Le Mans Wins Health & Safety Trophy!

Proud moment! Our Le Mans site has been awarded the Health & Safety at Work Trophy at the first Responsible Care West Atlantic Awards 🎉
This win celebrates our approach and Safety First mindset, empowering teams to spot risks and drive rapid improvements on the shop floor.

👏 Huge Bravo to our Le Mans teams — your dedication keeps us delivering world-class solutions for partners worldwide.

🇫🇷 Honored to welcome Bruno Bonnell (SGPI) and Sébastien Jallet (Préfet de la Sarthe - ) to our Axplora Le Mans site!

We showcased our new GMP workshop — built to the highest standards for HPAPI manufacturing and supported by the investment plan — capable of producing up to 1.5 kg batches of next-gen payloads like Auristatines and Tecans, driving innovation in oncology therapies.

With 20+ years of ADC expertise, 250+ GMP batches delivered, and 6 FDA-approved ADCs, Axplora continues to power the future of oncology.

🌿 Vizag Goes Silver! 🌿
We’re thrilled to share that our PharmaZell Vizag site has jumped from Bronze to in the EcoVadis sustainability rating — landing in the top 15% globally with a score of 74/100! 💥

This milestone honors our team’s bold commitment to sustainable excellence and responsible innovation. 🌍

🚀 Hats off to our Vizag heroes — leading the way for a greener future!

At Axplora, sustainability is in our DNA.